Appointment booking for Dr. Ranjeet Singh, MD is currently not available.Dr. Ranjeet Singh, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Ranjeet Singh, MD (he/him) is a Nephrologist in Tempe, AZ with over 12 years of experience. What is your opinion of Dr. Ranjeet Singh, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 12 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ranjeet Singh, MD has received over $1,372 which includes payments from the following companies:
$307.62 from Amgen Inc.
$207.42 from AstraZeneca Pharmaceuticals LP
$166.24 from Relypsa, Inc.
$130.17 from Otsuka America Pharmaceutical, Inc.
$94.32 from AKEBIA THERAPEUTICS INC
$89.97 from Fresenius USA Marketing, Inc.
$82.63 from Shire North American Group Inc
$53.45 from Daiichi Sankyo Inc.
$45.30 from Alexion Pharmaceuticals, Inc.
$42.32 from Mallinckrodt Enterprises LLC
$32.08 from Mallinckrodt Hospital Products Inc.
$25.72 from OPKO Pharmaceuticals, LLC
$21.41 from Baxter Healthcare
$19.86 from Noden Pharma USA Inc
$14.78 from GENZYME CORPORATION
$14.36 from Mallinckrodt LLC
$13.40 from Ironwood Pharmaceuticals, Inc
$11.39 from Novartis Pharmaceuticals Corporation
Payments received by Dr. Ranjeet Singh, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!